Betti, Marco et al. published their research in Journal of Medicinal Chemistry in 2019 | CAS: 6515-58-8

3-(Bromomethyl)benzoic acid (cas: 6515-58-8) belongs to organobromine compounds. Most organobromine compounds, like most organohalide compounds, are relatively nonpolar. Commercially available organobromine pharmaceuticals include the vasodilator nicergoline, the sedative brotizolam, the anticancer agent pipobroman, and the antiseptic merbromin. Formula: C8H7BrO2

Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity was written by Betti, Marco;Catarzi, Daniela;Varano, Flavia;Falsini, Matteo;Varani, Katia;Vincenzi, Fabrizio;Pasquini, Silvia;di Cesare Mannelli, Lorenzo;Ghelardini, Carla;Lucarini, Elena;Dal Ben, Diego;Spinaci, Andrea;Bartolucci, Gianluca;Menicatti, Marta;Colotta, Vittoria. And the article was included in Journal of Medicinal Chemistry in 2019.Formula: C8H7BrO2 This article mentions the following:

A new series of amino-3,5-dicyanopyridines was synthesized and biol. evaluated in order to further investigate the potential of this scaffold to obtain adenosine receptor (AR) ligands. In general, the modifications performed have led to compounds having high to good human (h) A1AR affinity and an inverse agonist profile. While most of the compounds are hA1AR-selective, some derivatives behave as mixed hA1AR inverse agonists/A2A and A2B AR antagonists. The latter compounds showed that they reduce oxaliplatin-induced neuropathic pain by a mechanism involving the alpha7 subtype of nAchRs, similar to the nonselective AR antagonist caffeine, taken as the reference compound Along with the pharmacol. evaluation, chem. stability of Me 3-(((6-amino-3,5-dicyano-4-(furan-2-yl)pyridin-2-yl)sulfanyl)methyl)benzoate I was assessed in plasma matrixes (rat and human), and mol. modeling studies were carried out to better rationalize the available structure-activity relationships. In the experiment, the researchers used many compounds, for example, 3-(Bromomethyl)benzoic acid (cas: 6515-58-8Formula: C8H7BrO2).

3-(Bromomethyl)benzoic acid (cas: 6515-58-8) belongs to organobromine compounds. Most organobromine compounds, like most organohalide compounds, are relatively nonpolar. Commercially available organobromine pharmaceuticals include the vasodilator nicergoline, the sedative brotizolam, the anticancer agent pipobroman, and the antiseptic merbromin. Formula: C8H7BrO2

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary